why choose us

First received: June 24, 2024

Clinical Trial: OSCAR I STUDY - The ONCObind CTC Removal Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pancreatic Ductal Adenocarcinoma (PDAC)

Study Type: INTERVENTIONAL


Official Title: Prospective Single-Arm Feasibility Study to Determine the Capacity of the Onco-Seraph 100 Microbind® Affinity Blood Filter (Onco-Seraph 100) to Remove Circulating Tumor Cells From the Blood of Patient

Brief Summary: This study is a Prospective Single Arm Open Label Feasibility trial to evaluate the initial safety and signal of efficacy of a novel extracorporeal blood purification (EBP) procedure in metastatic PDAC refractory to systemic therapy.Site selection will be dependent upon the site's familiarity with extracorporeal blood purification platforms as well as the diagnosis and management of PDAC.Adults (18 years old and older, ECOG PS of equal or less than 2) with a diagnosis of PDAC as defined histologically…

Read more